{"entity":{"id":"nct06030258","kind":"trial","name":"IN10018 Combination Therapy in Treatment-naïve ES-SCLC","aka":[],"tldr":"A phase 1/2 trial of IN10018, Tislelizumab, Carboplatin in small-cell lung cancer, run by InxMed (Shanghai) Co., Ltd., now recruiting.","summary":"IN10018 Combination Therapy in Treatment-naïve ES-SCLC is a phase 1/2 interventional study registered as NCT06030258 by InxMed (Shanghai) Co., Ltd., with 120 participants planned, started 2023-10-30 and due to reach its primary completion in 2025-12-24. Interventions recorded: IN10018, Tislelizumab, Carboplatin, Etoposide. Conditions listed: Small Cell Lung Cancer Extensive Stage. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06030258","url":"https://clinicaltrials.gov/study/NCT06030258"}],"tags":["ctgov-ingest"],"related":[],"cancers":["sclc"],"sections":[],"technologies":[],"targets":[],"drugs":["in10018","tislelizumab","carboplatin","etoposide"],"companies":["inxmed-shanghai"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06030258","phase":"1/2","setting":"A Phase Ib/II Clinical Trial to Evaluate the Anti-tumor Efficacy, Safety, Tolerability, and Pharmacokinetics of IN10018 Combined With Anti-PD-1/L1 Antibody and Chemotherapy as First-line Treatment in Extensive-stage Small Cell Lung Cancer","sponsor":"InxMed (Shanghai) Co., Ltd.","enrolled":120,"outcomes":[]},"route":"/trials/nct06030258/","neighbours":{"cancer":[{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"drug":[{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/"},{"id":"etoposide","kind":"drug","name":"Etoposide","route":"/drugs/etoposide/"},{"id":"in10018","kind":"drug","name":"IN10018","route":"/drugs/in10018/"},{"id":"tislelizumab","kind":"drug","name":"Tislelizumab","route":"/drugs/tislelizumab/"}],"company":[{"id":"inxmed-shanghai","kind":"company","name":"InxMed (Shanghai)","route":"/companies/inxmed-shanghai/"}]}}